Luba Greenwood

CIK: 0001853815

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

INAB

IN8BIO, INC.

Director

TRAW

Traws Pharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

INAB
IN8BIO, INC.
May 9, 2026
Award(A)
Stock Option (right to buy)
Direct
22K shares-
INAB
IN8BIO, INC.
May 8, 2025
Award(A)
Stock Option (right to buy)
Direct
63.2K shares-
INAB
IN8BIO, INC.
Dec 19, 2024
Award(A)
Stock Option (right to buy)
Direct
39.4K shares-
TRAW
Traws Pharma, Inc.
Sep 16, 2024
Award(A)
Stock Option (Right to Purchase)
Direct
164K shares-

		Type	Shares	Price		Ownership
May 9, 2026	INAB IN8BIO, INC.	Award(A) Stock Option (right to buy)	22,000	-	-	Direct
May 8, 2025	INAB IN8BIO, INC.	Award(A) Stock Option (right to buy)	63,150	-	-	Direct
Dec 19, 2024	INAB IN8BIO, INC.	Award(A) Stock Option (right to buy)	39,449	-	-	Direct
Sep 16, 2024	TRAW Traws Pharma, Inc.	Award(A) Stock Option (Right to Purchase)	164,000	-	-	Direct

1-4 of 4 transactions

About Greenwood Luba

Greenwood Luba (SEC CIK 0001853815) files insider reports with the SEC as Director of IN8BIO, INC. (INAB) and Director of Traws Pharma, Inc. (TRAW).

Signal8 holds 5 ownership filings by Greenwood Luba (1 Form 3, 4 Form 4), filed between Sep 17, 2024 and May 12, 2026. Those filings report 4 transactions, from Sep 16, 2024 to May 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Greenwood Luba's filings is in NEW YORK, NY.

Recent filings by Greenwood Luba

May 9, 2026: Grant or award of INAB derivative securities (Form 4, code A).
May 8, 2025: Grant or award of INAB derivative securities (Form 4, code A).
Dec 19, 2024: Grant or award of INAB derivative securities (Form 4, code A).
Sep 16, 2024: Grant or award of TRAW derivative securities (Form 4, code A).

Other insiders filing for IN8BIO, INC. (INAB)

FAIRBAIRN EMILY, Director
Ho William Tai-Wei, CEO
Lamb Lawrence, EVP and CSO
McCall Patrick, CHIEF FINANCIAL OFFICER
Epperly Corinne, Director
Rochlin Kate, President and COO

How to read Form 4 transaction codes